Sorafenib for the Treatment of Hepatocellular Carcinoma: A Single-centre Real-world Study

BACKGROUND: Sorafenib is an oral multi-kinase inhibitor used for the treatment of hepatocellular carcinoma. Its efficacy in randomised controlled trials was demonstrated in patients with well-preserved liver function and good functional status. In the real-world setting, treatment is often offered t...

Descripción completa

Detalles Bibliográficos
Autores principales: Hanzel, Jurij, Kosir Bozic, Tajda, Stabuc, Borut, Jansa, Rado
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sciendo 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7276638/
https://www.ncbi.nlm.nih.gov/pubmed/32463391
http://dx.doi.org/10.2478/raon-2020-0027

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7276638/
https://www.ncbi.nlm.nih.gov/pubmed/32463391
http://dx.doi.org/10.2478/raon-2020-0027

Ejemplares similares